Prediction of early-stage melanoma recurrence using clinical and histopathologic features

Prediction of early-stage melanoma recurrence using clinical and histopathologic features

Abstract Prognostic analysis for early-stage (stage I/II) melanomas is of paramount importance for customized surveillance and treatment plans. Since immune checkpoint inhibitors have recently been approved for stage IIB and IIC melanomas, prognostic tools to identify patients at high risk of recurr...

Full description

Bibliographic Details
Main Authors: Guihong Wan, Nga Nguyen, Feng Liu, Mia S. DeSimone, Bonnie W. Leung, Ahmad Rajeh, Michael R. Collier, Min Seok Choi, Munachimso Amadife, Kimberly Tang, Shijia Zhang, Jordan S. Phillipps, Ruple Jairath, Nora A. Alexander, Yining Hua, Meng Jiao, Wenxin Chen, Diane Ho, Stacey Duey, István Balázs Németh, Gyorgy Marko-Varga, Jeovanis Gil Valdés, David Liu, Genevieve M. Boland, Alexander Gusev, Peter K. Sorger, Kun-Hsing Yu, Yevgeniy R. Semenov
Format: Article
Language:English
Published: Nature Portfolio 2022-10-01
Series:npj Precision Oncology
Online Access:https://doi.org/10.1038/s41698-022-00321-4

Internet

https://doi.org/10.1038/s41698-022-00321-4

Similar Items